Pages that link to "Q27014027"
Jump to navigation
Jump to search
The following pages link to Early diagnosis of pancreatic cancer: challenges and new developments (Q27014027):
Displaying 50 items.
- How Grim is Pancreatic Cancer? (Q26740598) (← links)
- Current status and progress of pancreatic cancer in China (Q26799739) (← links)
- Is routine drainage necessary after pancreaticoduodenectomy? (Q26823367) (← links)
- Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. (Q30372356) (← links)
- The use of multidimensional data to identify the molecular biomarker for pancreatic ductal adenocarcinoma (Q30685971) (← links)
- Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls (Q34463741) (← links)
- Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature (Q34990040) (← links)
- Development of a multiplex autoantibody test for detection of lung cancer (Q35154906) (← links)
- Immediate early response gene X-1, a potential prognostic biomarker in cancers (Q35240656) (← links)
- Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation (Q35506933) (← links)
- Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies (Q35678051) (← links)
- Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer (Q35842473) (← links)
- Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma (Q35964357) (← links)
- Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. (Q36042474) (← links)
- Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics (Q36118351) (← links)
- Significance of microRNA-based biomarkers for pancreatic cancer (Q36241870) (← links)
- Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer. (Q36534730) (← links)
- Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization (Q36790514) (← links)
- Pancreatic cancer diagnosis by free and exosomal miRNA. (Q37382231) (← links)
- Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. (Q37714287) (← links)
- Mucins in pancreatic cancer and its microenvironment (Q38121746) (← links)
- Biomarkers for early diagnosis of pancreatic cancer (Q38265405) (← links)
- Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma (Q38387283) (← links)
- Cancer proteomics: developments in technology, clinical use and commercialization (Q38543009) (← links)
- ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer (Q38601572) (← links)
- Exosomes: potential for early detection in pancreatic cancer (Q38727631) (← links)
- In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody (Q38765928) (← links)
- Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy (Q39028976) (← links)
- Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review (Q39070481) (← links)
- A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study (Q41985946) (← links)
- Increased erythropoietin levels as a biomarker of pancreatic adenocarcinoma: A case report (Q42252179) (← links)
- DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma (Q45017704) (← links)
- Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy (Q47094133) (← links)
- Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis (Q47146321) (← links)
- A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline (Q47418676) (← links)
- Clinical significance of MUC13 in pancreatic ductal adenocarcinoma (Q47558595) (← links)
- Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data (Q47578665) (← links)
- Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival (Q47679622) (← links)
- What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). (Q47939391) (← links)
- Protein-induced fluorescence enhancement of two-photon excitable water-soluble diketopyrrolopyrroles (Q47956418) (← links)
- CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience (Q48113448) (← links)
- Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis. (Q49502117) (← links)
- The Immunohistochemical Expression MTA 1 Protein and its Prognostic Value in Pancreatic Cancer. (Q50932430) (← links)
- Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes. (Q52595056) (← links)
- [Will molecular diagnostics become established in pancreatic pathology?]. (Q54397309) (← links)
- Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies. (Q54944542) (← links)
- Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer. (Q54976945) (← links)
- Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics. (Q54980764) (← links)
- Tumor targeted mesoporous silica-coated gold nanorods facilitate detection of pancreatic tumors using Multispectral optoacoustic tomography (Q57353110) (← links)
- Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model (Q57826813) (← links)